Comparison of the effects of human adipose and bone marrow mesenchymal stem cells on T lymphocytes

Cell Biology International

Volumn 37, Issue 1, 2013, Pages 11-18

  Xishan, Zhu ^a   Baoxin, He ^a   Xinna, Zhou ^a   Jun, Ren ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Adipose derived mesenchymal stem cells (aMSCs); Bone marrow derived mesenchymal stem cells (bMSCs); Cell biology and transplantation; Immune regulation

Indexed keywords

BETA1 INTEGRIN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 14; PLATELET DERIVED GROWTH FACTOR BB; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2;

ADIPOSE TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOPHENOTYPING; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INDIA; INTERMETHOD COMPARISON; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; MULTIPOTENT STEM CELL; PHENOTYPE; RECIPIENT; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ADIPOSE TISSUE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; T-LYMPHOCYTES;

EID: 84874719666     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10002     Document Type: Article

References (35)

1. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822.
2. Bukowiecki LJ, Geloen A, Collet AJ (1986) Proliferation and differentiation of brown adipocytes frominterstitial cells during cold acclimation. Am J Physiol 250: c880-7.
3. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC (2005) Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332 (2): 370-379.
4. Chan J, Waddington SN, O'Donoghue K, Kurata H, Guillot PV, Gotherstrom C, Themis M, Morgan JE, Fisk NM (2007) Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. Stem Cells 25 (4): 875-884.
5. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372.
6. Cutler AJ, Limbani V, Girdlestone J, Navarrete CV (2010) Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J Immunol 185 (11): 6617-6623 [Epub 2010 Oct 27].
7. De Ugarte DA, Alfonso Z, Zuk PA, Elbarbary A, Zhu M, Ashjian P, Benhaim P, Hedrick MH, Fraser JK (2003) Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 89: 267-270.
8. Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, You S, Deng H, Zhao RC (2004) Allogeneic bone marrow-derived flk-1+ Sca-1-mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol 32 (9): 861-867.
9. Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, You S, Deng H, Murad F, Zhao RC (2005) Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue. Tissue Eng 11 (1-2): 110-119.
10. Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S (2011) Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 20 (5): 655-667.
11. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC (2003) Multiorgan engraftment and multilineage differentiation by human fetal bone marrow Flk1+/CD31-/CD34- progenitors. J Hematother Stem Cell Res 12 (6): 603-613.
12. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC (2004) Systemic infusion of FLK1(+)mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78 (1): 83-88.
13. Fang B, Liao L, Shi M, Yang S, Zhao RC (2004) Multipotency of Flk1CD34 progenitors derived from human fetal bone marrow. J Lab Clin Med 143 (4): 230-240.
14. Fang B, Song YP, Liao LM, Han Q, Zhao RC (2006) Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 38 (5): 389-390.
15. Friedenstein A (1982) Stromal bone marrow cells and the hematopoietic microenvironment. Arkh Patol 44 (10): 3-11.
16. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F (2005) Bone marrow mesenchymal stem cells induce division arrest energy of activated T cells. Blood 105: 2821-2827.
17. Guo H, Fang B, Liao L, Zhao Z, Liu J, Chen H, Hsu SH, Cui Q, Zhao RC (2003) Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-)CD34(-) cells. Exp Hematol 31 (7): 650-658.
18. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, Mao N (2005) Humanmesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105: 4120-4126.
19. Johann PD, Vaegler M, Gieseke F, Mang P, Armeanu-Ebinger S, Kluba T, Handgretinger R, Müller I (2010) Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity. BMC Cancer 10: 501.
20. Kasper G, Dankert N, Tuischer J, Hoeft M, Gaber T, Glaeser JD, Zander D, Tschirschmann M, Thompson M, Matziolis G, Duda GN (2007) Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells 25 (4): 903-910.
21. Krause U, Harter C, Seckinger A, Wolf D, Reinhard A, Bea F, Dengler T, Hardt S, Ho A, Katus HA, Kuecherer H, Hansen A (2007) Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart. Stem Cells Dev 16 (1): 31-37.
22. Li F, Bronson S, Niyibizi C (2010) Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cell Biochem 109 (4): 643-52.
23. Mizuno H, Zuk PA, Zhu M, Lorenz HP, Benhaim P, Hedrick MH (1999) Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 109: 199-209.
24. Naito H, Dohi Y, Zimmermann W, Tojo T, Takasawa S, Eschenhagen T, Taniguchi S (2011) The effect of mesenchymal stem cell osteoblastic differentiation on the mechanical properties of engineered bone-like tissue. Tissue Eng A 17 (17-18): 2321-2329.
25. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud L, Casteilla L, Blancher A (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparisonwith bone marrow mesenchymal stem cells. Br J Haematol 129 (1): 118-129.
26. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81 (10): 1390-1397.
27. Rodbell M (1964) Metabolism of isolated fat cells. Effects of hormone on fat metabolism and liplysis. J Biol Chem 239: 375-80.
28. Semenov OV, Koestenbauer S, Riegel M, Zech N, Zimmermann R, Zisch AH, Malek A (2010)Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. Am J Obstet Gynecol 202 (2): 193.e1-13 [Epub 2009 Dec 24].
29. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24 (1): 74-85.
30. Sundin M, D'arcy P, Johansson CC, Barrett AJ, Lönnies H, Sundberg B, Nava S, Kiessling R, Mougiakakos D, Le Blanc K (2011)Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity? J Immunother 34 (4): 336-342
31. Tadokoro M, Matsushima A, Kotobuki N, Hirose M, Kimura Y, Tabata Y, Hattori K, Ohgushi H (2011) Bone morphogenetic protein-2 in biodegradable gelatin and β-tricalcium phosphate sponges enhances the in vivo bone-forming capability of bone marrow mesenchymal stem cells. J Tissue Eng RegenMed 6 (4): 253-260.
32. Wada N, Bartold PM, Gronthos S (2011) Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells. Stem Cells Dev 20 (4): 647-659 [Epub 2010 Oct 12].
33. Weng JY, Du X, Geng SX, Peng YW, Wang Z, Lu ZS, Wu SJ, Luo CW, Guo R, Ling W, Deng CX, Liao PJ, Xiang AP (2010) Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant 45 (12): 1732-40 [Epub 2010 Sep 6].
34. Xishan Z, Guangyu A, Yuguang S, Hongmei Z (2011) The research on the immuno-modulatory defect of mesenchymal stem cell from chronic myeloid leukemia patients. J Exp Clin Cancer Res 30 (1): 47.
35. Zhang W, Ge W, Li C, You S, Liao L, Han Q, Deng W, Zhao RC (2004) Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13 (3): 263-271.